Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 23576086)

1.

Should maintenance therapy be performed in ulcerative proctitis? How long should it be continued?

Yönal O, Hatemi G, Kaymakoğlu S.

Turk J Gastroenterol. 2012;23 Suppl 2:21-4. Review. No abstract available.

PMID:
23576086
2.

[Intestinal mucosa as the focal point. In distal ulcerative colitis relief with topical therapy].

[No authors listed]

MMW Fortschr Med. 2004 Jun 3;146(23):62-3. German. No abstract available.

PMID:
15373138
3.

Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.

Ardizzone S, Doldo P, Ranzi T, Sturniolo GC, Giglio LA, Annese V, D'Arienzo A, Gaia E, Gullini S, Riegler G, Valentini M, Massa P, Del Piano M, Rossini F, Guidetti CS, Pera A, Greinwald R, Bianchi Porro G.

Ital J Gastroenterol Hepatol. 1999 Nov;31(8):677-84.

PMID:
10730559
4.

Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.

Cortot A, Maetz D, Degoutte E, Delette O, Meunier P, Tan G, Cazals JB, Dewit O, Hebuterne X, Beorchia S, Grunberg B, Leprince E, D'Haens G, Forestier S, Idier I, Lémann M.

Am J Gastroenterol. 2008 Dec;103(12):3106-14. doi: 10.1111/j.1572-0241.2008.02152.x.

PMID:
19086960
5.

Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.

Richter JM, Kushkuley S, Barrett JA, Oster G.

Aliment Pharmacol Ther. 2012 Aug;36(3):248-56. doi: 10.1111/j.1365-2036.2012.05175.x. Epub 2012 Jun 12.

PMID:
22690748
6.

Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.

Hanauer S, Good LI, Goodman MW, Pizinger RJ, Strum WB, Lyss C, Haber G, Williams CN, Robinson M.

Am J Gastroenterol. 2000 Jul;95(7):1749-54.

PMID:
10925979
7.

[A case of left-sided ulcerative colitis successfully treated with mesalazine enema but not steroid suppository].

Yamamoto S, Miyata Y, Kato J, Hasuike S, Ideguchi T, Minami H, Hori T, Hirono S, Hayashi K, Tsubouchi H.

Nihon Shokakibyo Gakkai Zasshi. 2000 Jul;97(7):910-3. Japanese. No abstract available.

PMID:
10934875
9.

Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.

Andus T, Kocjan A, Müser M, Baranovsky A, Mikhailova TL, Zvyagintseva TD, Dorofeyev AE, Lozynskyy YS, Cascorbi I, Stolte M, Vieth M, Dilger K, Mohrbacher R, Greinwald R; International Salofalk Suppository OD Study Group.

Inflamm Bowel Dis. 2010 Nov;16(11):1947-56. doi: 10.1002/ibd.21258.

PMID:
20310020
10.

Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents.

Heyman MB, Kierkus J, Spénard J, Shbaklo H, Giguere M.

Inflamm Bowel Dis. 2010 Nov;16(11):1931-9. doi: 10.1002/ibd.21256.

11.

[Treating distal ulcerative colitis intrarectally. Foam instead of enema, low volume rather than high volume].

[No authors listed]

MMW Fortschr Med. 2008 Apr 10;150(15):44. German. No abstract available.

PMID:
18510119
12.

Ulcerative proctitis: a review of pharmacotherapy and management.

Lakatos PL, Lakatos L.

Expert Opin Pharmacother. 2008 Apr;9(5):741-9. doi: 10.1517/14656566.9.5.741. Review.

PMID:
18345952
13.

Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis.

Gionchetti P, Rizzello F, Venturi A, Brignola C, Ferretti M, Peruzzo S, Campieri M.

Aliment Pharmacol Ther. 1997 Dec;11(6):1053-7.

PMID:
9663829
14.

Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation -- a placebo-controlled study.

Watanabe M, Nishino H, Sameshima Y, Ota A, Nakamura S, Hibi T.

Aliment Pharmacol Ther. 2013 Aug;38(3):264-73. doi: 10.1111/apt.12362. Epub 2013 Jun 5.

PMID:
23734840
15.

Letter: real-life management of new onset ulcerative colitis and proctitis.

Domènech E, Gisbert JP.

Aliment Pharmacol Ther. 2012 Oct;36(7):685-6; author reply 686. doi: 10.1111/apt.12003. No abstract available.

PMID:
22966799
16.

Treatment of distal ulcerative colitis: now the patients have the choice.

Schölmerich J.

Ital J Gastroenterol Hepatol. 1999 Nov;31(8):685-7. No abstract available.

PMID:
10730560
17.

What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?

Riley SA.

Gut. 1998 Jun;42(6):761-3. No abstract available.

18.

Mesalamine for ulcerative colitis.

[No authors listed]

Med Lett Drugs Ther. 1988 May 20;30(766):53-4. No abstract available.

PMID:
3283508
19.

Epidermal growth factor for ulcerative colitis.

Farrell RJ.

N Engl J Med. 2003 Jul 24;349(4):395-7. No abstract available.

PMID:
12878748
20.

[Once daily mesalazine for long-term remission. Ulcerative colitis: maintenance therapy becomes easier].

[No authors listed]

MMW Fortschr Med. 2008 Mar 13;150(11):44-5. German. No abstract available.

PMID:
18447278
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk